Inhibition of PINK1 senses ROS signaling to facilitate neuroblastoma cell pyroptosis

Yuyuan Zhu1,2, Min Cao1,2, Yancheng Tang1,2

  • 1The Affiliated XiangTan Central Hospital of Hunan University, School of Biomedical Sciences, Hunan University, Changsha, Hunan, China.

Autophagy
|March 31, 2025
PubMed

Insights

Inhibition of PTEN induced kinase 1 (PINK1) in neuroblastoma enhances reactive oxygen species (ROS) and triggers pyroptosis, offering a new cancer therapy strategy. This study reveals PINK1 deficiency promotes pyroptosis via the BAX-caspase-GSDME pathway.

Area of Science:

  • Cell Biology
  • Oncology
  • Mitochondrial Biology

Background:

  • Mitochondria are key sources of reactive oxygen species (ROS), influencing cancer cell death pathways like pyroptosis.
  • PTEN induced kinase 1 (PINK1)-mediated mitophagy removes damaged mitochondria and reduces ROS, promoting cell survival.
  • The role of PINK1 and ROS in neuroblastoma pyroptosis is not well understood.

Purpose of the Study:

  • To investigate the regulation of pyroptosis by PINK1 and ROS in neuroblastoma cells.
  • To elucidate the signaling pathway involved in PINK1-modulated pyroptosis.
  • To evaluate the therapeutic potential of targeting PINK1 in neuroblastoma treatment.

Main Methods:

  • Inhibition of PINK1 using AC220 or genetic knockout (PINK1).
  • Assessment of mitophagy, ROS production, TOMM20 oxidation, and BAX activation.
  • Analysis of cytochrome c release, caspase activation, and Gasdermin E (GSDME) cleavage.
  • In vivo studies evaluating the combined effect of PINK1 inhibition and ethacrynic acid (EA).

Main Results:

  • PINK1 inhibition or deficiency impaired mitophagy and increased ROS production in neuroblastoma cells.
  • This led to TOMM20 oxidation, BAX activation, cytochrome c release, and subsequent caspase-3 and GSDME activation, inducing pyroptosis.
  • Combined inhibition of PINK1 and treatment with the ROS-inducing drug ethacrynic acid (EA) showed enhanced anti-tumor effects in vivo.

Conclusions:

  • PINK1 deficiency sensitizes neuroblastoma cells to ROS signaling, promoting pyroptosis through the BAX-caspase-GSDME pathway.
  • Targeting PINK1 enhances the efficacy of ROS-inducing agents, presenting a novel therapeutic strategy for neuroblastoma.
  • This study provides a promising intervention strategy for neuroblastoma by inducing pyroptosis.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K